The Medical affairs groups are a growing vital sector in
today's bio pharmaceutical industry in providing hospital consultants, key
opinion leaders (KOL's), regulatory agencies and healthcare professionals with
scientific and medical information relating to the value and correct usage of the
products.
Medical affairs personnel strive for the highest scientific
integrity so as to produce successful clinical trials and supply the greatest
support for the market. Medical affairs groups perform many activities often
overlapping with sales, Medical marketing, clinical growth, and customer
service.
Sales groups may be ill-positioned to accurately present the
new product to physicians and quite often need help in making more expert
presentations. Medical affairs groups might help in developing appropriate
positioning for new releases and help to leveraging the newer indications to
come.
Pharmaceutical companies spend tremendous resources for
development of new drug treatments. A great deal of time is spent in doing
research on potential health-related products and medicines.
While considering the distinctions between post marketing
scientific tests and clinical registration demos, medical affairs can fill the
requirement for the studies done post approval.
Medical Affairs Role
in Functional Areas:
Medical Affairs acts as the central focal point for
different therapeutic areas of sales, marketing and research. Medical Affairs
work closely with various functional departments such as:
Medical Writing
Scientific Development and Reviewing connected with Product
profiles, monographs, package deal insert/ patient information booklet,
pharmacology and toxicology parts of registration dossiers with constant
updates.
Preparation of
Professional medical Development Plan
Providing therapeutic and scientific content for development
of study standard protocol
Designing and implementation connected with pharmacoeconomic
studies
Reviewing along with approval of regulatory submission,
manuscripts, abstracts, posters as well as other scientific documents.
Medical Monitoring:
Medical affairs are the Primary medical contact towards the
sponsor, investigative website, and project group.
Medical Affairs supports the look, conduct and evaluation of
clinical research and involves continuous data maintenance as well as
management.
Involves in talk on study feasibility together with Key
Opinion Leaders as well as other potential investigators with regards to
possible logistical requirements of the study protocol as well as responds to subject
eligibility and disengagement questions.
A Medical affairs team is usually responsible for Medical
Monitoring:
Medical affairs are the Primary medical contact towards the
sponsor, investigative website, and project group.
Medical Affairs supports the look, conduct and evaluation of
clinical research and involves continuous data maintenance as well as
management.
Involves in talk on study feasibility together with Key
Opinion Leaders as well as other potential investigators with regards to
possible logistical requirements of the study protocol as well as responds to
subject eligibility and disengagement questions.
A Medical affairs team is usually responsible for clinical
trials Protocol and study linked training for researchers and site personnel.
During Pre launch cycle of drug the actual Medical Affairs
team will establish a KOL strategy for this product based upon prescriber's
interest in research and education for your given indication. Then MA
departments will target prospective KOLs and connect to them regarding the
actual science behind the revolutionary product, ongoing trials like the
balanced information regarding both positive along with negative results. Also
discuss the important thing data from healthcare meetings and summaries of
changes to apply the guidelines. In addition it will conduct additional
education activities of Sales/Marketing individuals to raise awareness of the
disease state, current therapeutics, and current gaps in sufferer care.
Further, the interests of the KOLs will be assessed during discussions to find
out the appropriate scientific exchange and any prospective opportunities for
potential investigator-initiated trials (IITs).
At the time of product launch MA was responsible in ensuring
clear understanding on utilization of the product by the prescribers. They
exchange technological information regarding compound-specific characteristics
and physician perceptions of the drug profile. In those times MA will perform an
evaluation of IIT proposals that might generate a Step IV strategy which will
further differentiate the merchandise post-marketing.
During the Post-launch period of a drug, MA seeks
suggestions from KOLs and along with this, it resolves the queries regarding
the product ensuring that they know exactly how you can use the product or
service. MA maintains the collection of information regarding the acceptance of
the product among prescribers along with issues being confronted by the drug.
These valuable data will update marketing work as deemed necessary. Further
discussions upon clinical practice roles and potential extra indications with
KOL's facilitate the commencement regarding IITs and Step IV studies.
Conclusion:
Medical Affairs is the majority of credible link with
external stakeholders and also play a progressively more important role in
communicating the product or service value message to physicians in an
objective and ethical manner. They provide assistance in dissemination of
technological information regarding current products to regulating agencies and
healthcare professionals. Thus Medical Affairs play an important role in
establishing appropriate positioning for new items and help to help leverage the newer indications in the
future.